The purpose of iVascular is to provide advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Thanks to the know-how provided by our technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to produce vascular devices from basic raw materials (plastics, polymers, metals...) to the final device. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device. In this way, we guarantee the highest quality standards in all our products. Through its direct and indirect sales network, iVascular is present in more than 80 countries around the world and provides a full range of products for interventional cardiology, endovascular procedures, and neurointervention. For more information about iVascular, please visit www.ivascular.global. If you have any questions or comments, we are ready to help you out by email at info@ivascular.global
Looking for a particular iVascular employee's phone or email?
The iVascular annual revenue was $28.3 million in 2026.
Enric Santodomingo I Tresserras is the Chief Financial Officer Deputy of iVascular.
205 people are employed at iVascular.
The NAICS codes for iVascular are [33, 339].
The SIC codes for iVascular are [38, 384].